Addex Therapeutics Ltd
SIX:ADXN
Addex Therapeutics Ltd
SIX:ADXN
Price:
0.038
CHF
-2.56%
Market Closed
Market Cap:
CHf7m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Addex Therapeutics Ltd
SIX:ADXN
|
CH |
|
Kushim Inc
TSE:2345
|
JP |
|
S
|
San Miguel Corp
OTC:SMGBF
|
PH |
|
G
|
Green Planet Bio Engineering Co Ltd
OTC:GPLB
|
US |
|
Natura & Co Holding SA
BOVESPA:NTCO3
|
BR |
|
S
|
Swarnsarita Jewels India Ltd
BSE:526365
|
IN |
|
Flower King Eco-Engineering Inc
SSE:603007
|
CN |
|
C
|
CMC Corp
TSE:2185
|
JP |
|
L
|
Learnd SE
XETRA:LRND
|
LU |
|
E
|
Eco Wave Power Global AB (publ)
NASDAQ:WAVE
|
SE |
Relative Value
The Relative Value of one
ADXN
stock under the Base Case scenario is
hidden
CHF.
Compared to the current market price of 0.038 CHF,
Addex Therapeutics Ltd
is
hidden
.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
ADXN Relative Value
HIDDEN
Multiples Across Competitors
ADXN Competitors Multiples
Addex Therapeutics Ltd Competitors
Addex Therapeutics Ltd Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| CH |
|
Addex Therapeutics Ltd
SIX:ADXN
|
7m CHF | 12.2 | -1.2 | -2.4 | -2.3 | |
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD | 33 690 872.8 | -160 127.7 | -194 446.1 | -192 227.3 | |
| US |
|
Abbvie Inc
NYSE:ABBV
|
366.3B USD | 6 | 87.5 | 14.5 | 20.2 | |
| US |
|
Exact Sciences Corp
NASDAQ:EXAS
|
355.9B USD | 109.6 | -1 710.6 | 15 890.6 | -1 794.3 | |
| US |
|
Amgen Inc
NASDAQ:AMGN
|
190.8B USD | 5.2 | 24.7 | 14.3 | 14.3 | |
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
171.4B USD | 5.8 | 20.2 | 12.6 | 15.6 | |
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
113.9B USD | 9.6 | 29.2 | 22 | 23 | |
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR | 2 091 | -533.6 | -581 | -565.5 | |
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
78.4B USD | 5.5 | 17.6 | 13 | 14.9 | |
| AU |
|
CSL Ltd
ASX:CSL
|
67.2B AUD | 3.1 | 34.5 | 11.4 | 14.3 | |
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR | 20.1 | -61.8 | -66.6 | -60.1 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
